What is Neolitics?
Neolitics operates at the intersection of advanced spectroscopy and industrial automation. The company specializes in the deployment of its patented in-line Near Infra-Red Spectrometer (NIRS), branded as DNA. This hardware-software hybrid is engineered to optimize manufacturing output while simultaneously driving down operational expenditures. By integrating artificial intelligence for self-calibration and analyzer cloning, Neolitics addresses the critical pain points of downtime and precision in the pharmaceutical, food and beverage, and chemical sectors. Its ruggedized design ensures that the technology remains resilient in demanding industrial settings, effectively bridging the gap between laboratory-grade analysis and real-time factory floor execution.
How much funding has Neolitics raised?
Neolitics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Neolitics
PPP
Public-Private Partnership
What's next for Neolitics?
With this late-stage capital, Neolitics is poised to transition from a specialized technology provider to a foundational infrastructure partner for global manufacturing giants. The strategic roadmap likely involves expanding the footprint of its DNA platform across international markets and deepening its AI-driven analytical capabilities. By focusing on the scalability of its self-calibrating systems, the company aims to reduce the barrier to entry for automated quality control, potentially disrupting traditional, manual-heavy inspection processes. As the firm matures, the focus will shift toward securing long-term enterprise contracts and refining its software-as-a-service (SaaS) components to ensure recurring revenue streams and sustained competitive advantage in the Industry 4.0 landscape.
See full Neolitics company page
